AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$450M |
| 2 |
TJX Companies
TJX
|
+$377M |
| 3 |
JPMorgan Chase
JPM
|
+$340M |
| 4 |
Medtronic
MDT
|
+$295M |
| 5 |
Philip Morris
PM
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$475M |
| 2 |
Kroger
KR
|
+$411M |
| 3 |
Citigroup
C
|
+$338M |
| 4 |
ExxonMobil
XOM
|
+$290M |
| 5 |
Goldman Sachs
GS
|
+$274M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.65% |
| 2 | Technology | 15.1% |
| 3 | Healthcare | 13.76% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Industrials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
TETRA Technologies
TTI
$1.26B
| $403K | ﹤0.01% |
144,573
+20,000
| +16% | +$66.5K |
|
|
SCMP
2677
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $403K | ﹤0.01% |
38,362
+9,000
| +31% | +$91.7K |
|
2678
Angi Inc
ANGI
$196M
| $402K | ﹤0.01% |
3,140
+728
| +30% | +$71.8K |
|
|
RSO
2679
DELISTED
Resource Capital Corp.
RSO
| $402K | ﹤0.01% |
39,560
+6,000
| +18% | +$57.7K |
|
2680
Citizens
CIA
$192M
| $401K | ﹤0.01% |
54,309
+12,800
| +31% | +$84.5K |
|
|
TRQ
2681
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $400K | ﹤0.01% |
15,079
+8,168
| +118% | +$221K |
|
|
CSLT
2682
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $397K | ﹤0.01% |
95,750
+15,300
| +19% | +$59.7K |
|
|
WMC
2683
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $396K | ﹤0.01% |
3,840
+500
| +15% | +$51.3K |
|
2684
Rigel Pharmaceuticals
RIGL
$750M
| $395K | ﹤0.01% |
14,474
+2,860
| +25% | +$78.3K |
|
|
GARS
2685
DELISTED
Garrison Capital Inc.
GARS
| $395K | ﹤0.01% |
47,868
-62,486
| -57% | -$566K |
|
2686
Karyopharm Therapeutics
KPTI
$48M
| $393K | ﹤0.01% |
2,895
+700
| +32% | +$104K |
|
2687
QCR Holdings
QCRH
$1.7B
| $389K | ﹤0.01% |
+8,200
| New | +$369K |
|
2688
Atara Biotherapeutics
ATRA
$76.1M
| $388K | ﹤0.01% |
1,110
+368
| +50% | +$142K |
|
2689
Sunoco
SUN
$13.3B
| $388K | ﹤0.01% |
12,679
+710
| +6% | +$21.2K |
|
|
BLCM
2690
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $388K | ﹤0.01% |
3,320
+1,380
| +71% | +$171K |
|
2691
FlexShares International Quality Dividend Index Fund
IQDF
$1.17B
| $387K | ﹤0.01% |
+15,374
| New | +$385K |
|
2692
Ocular Therapeutix
OCUL
$2.02B
| $387K | ﹤0.01% |
41,700
+14,400
| +53% | +$139K |
|
2693
Ezcorp Inc
EZPW
$1.71B
| $386K | ﹤0.01% |
50,147
+2,600
| +5% | +$22.6K |
|
|
LGTY
2694
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $386K | ﹤0.01% |
37,492
+15,800
| +73% | +$171K |
|
2695
Option Care Health
OPCH
$3.56B
| $385K | ﹤0.01% |
35,475
+11,950
| +51% | +$90.9K |
|
|
SRGA
2696
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $384K | ﹤0.01% |
2,188
+220
| +11% | +$31.3K |
|
2697
Horizon Bancorp
HBNC
$1.04B
| $383K | ﹤0.01% |
+21,825
| New | +$379K |
|
2698
Dr. Reddy's Laboratories
RDY
$10.2B
| $383K | ﹤0.01% |
45,425
+6,385
| +16% | +$51.9K |
|
|
CMRX
2699
DELISTED
Chimerix, Inc.
CMRX
| $383K | ﹤0.01% |
70,200
+5,400
| +8% | +$28.4K |
|
2700
Peapack-Gladstone Financial
PGC
$812M
| $382K | ﹤0.01% |
+12,200
| New | +$374K |
|
Similar funds
AllianceBernstein's Q2 2017 Portfolio in Review
As of Q2 2017, AllianceBernstein held 3,267 positions worth $129B, up 2.9% from $126B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AllianceBernstein's Q2 2017 filing shows 278 new, 1,441 increased, 1,234 reduced and 121 closed positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 1,742,637 shares worth $86.5M. The largest sale was Wells Fargo, an estimated $475M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q2 2017 buy was Athene Holding Ltd. Class A Common Shares: 1,742,637 shares worth $86.5M.
- AllianceBernstein added most to McDonald's in Q2 2017, an estimated $450M increase.
- AllianceBernstein's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $475M.
- AllianceBernstein fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q2 2017, selling an estimated $119M.
- AllianceBernstein's ten largest holdings make up 15% of its $129B portfolio in Q2 2017.
- AllianceBernstein opened 278 new positions and closed 121 in Q2 2017.
- AllianceBernstein's portfolio value rose 2.9% quarter-over-quarter to $129B.
Based on AllianceBernstein's 13F filing for Q2 2017, filed 10 Aug 2017.